Sponsor content

Accelerating vaccine R&D through collaboration

Recognizing that even broad, multidisciplinary teams need external support, GSK has formed over 115 partnerships to help develop vaccines for the future. To download the full article, please sign in.

Go to the profile of GSK
May 23, 2016
1
0
Page of
Go to the profile of GSK

GSK

GSK is one of the world’s leading vaccine companies, involved in vaccine research, development and production. We have 15 vaccines in development and our broad portfolio of 39 vaccines prevent illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis. Globally, we have more than 16,000 people working to deliver nearly 2 (1.9) million vaccines every day, to people in around 90% (172) of the world’s countries. In 2015 we distributed around 690 million doses of vaccine, over 70% of them to least developed, low and middle income countries.

No comments yet.